Flavonoids isolated from cocoa have biological activities relevant to oxidant defenses, vascular health, tumor suppression, and immune function. The intake of certain dietary flavonoids, along with other dietary substances such as tocopherols, ascorbate, and carotenoids, is epidemiologically associated with a reduced risk of cardiovascular disease. Flavonoids have also been shown to modulate tumor pathology in vitro and in animal models. We took advantage of the conserved sequences found in tyrosine kinases to study the influence of cocoa fractions and controls on gene expression. We report that the pentameric procyanidin (molecular weight of 1442 daltons) fraction isolated from cocoa was a potent inhibitor of tyrosine kinase ErbB2 expression, a receptor important in angiogenesis regulation. Consistent with this primary observation, the cocoa flavonoid fraction also suppressed human aortic endothelial cell (HAEC) growth and decreased expression of two tyrosine kinases responsive to ErbB2 modulation, namely VEGFR-2/KDR and MapK 11/p38β2. These inhibitory effects were observed when HAECs were treated with the flavonol fraction (molecular weight 280 daltons) isolated from cocoa, which comprise the structural subunits from which the procyanidin flavonoid subclass is biosynthetically constructed. Down-regulation of ErbB2 and inhibition of HAEC growth by cocoa procyanidins may have several downstream implications, including reduced vascular endothelial growth factor (VEGF) activity and angiogenic activity associated with tumor pathology. These results suggest specific dietary flavonoids are capable of selectively inhibiting ErbB2 and therefore may offer important insight into the design of therapeutic agents that target tumors overexpressing ErbB2.
DillingerTL, BarrigaP, EscarcegaS, JimenezM, Salazar LoweD, GrivettiLE. Food of the gods: cure for humanity? A cultural history of the medicinal and ritual use of chocolate. J Nutr130:2057S–2072S, 2000.
2.
AdamsonGE, LazarusSA, MitchellAE, PriorRL, CaoG, JacobsPH, KremersBG, HammerstoneJF, RuckerRB, RitterKA, SchmitzHH. HPLC method for the quantification of procyanidins in cocoa and chocolate samples and correlation to total antioxidant capacity. J Agric Food Chem47:4184–4188, 1999.
3.
Kris-EthertonPM, DerrJ, MitchellDC, MustadVA, RussellME, McDonnellET, SalabskyD, PearsonTA. The role of fatty acid saturation on plasma lipids, lipoproteins, and apolipoproteins: I. Effects of whole food diets high in cocoa butter, olive oil, soybean oil, dairy butter, and milk chocolate on the plasma lipids of young men. Metabolism42:121–129, 1993.
4.
KozikowskiAP, TuckmantelW, BottcherG, RomanczykLJJr.Studies in polyphenol chemistry and bioactivity. 4.(1) Synthesis of trimeric, tetrameric, pentameric, and higher oligomeric epicatechin-derived procyanidins having all-4beta,8-interflavan connectivity and their inhibition of cancer cell growth through cell cycle arrest. J Org Chem68:1641–1658, 2003.
5.
KarimM, McCormickK, KappagodaCT. Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr130:2105S–2108S, 2000.
6.
ScheweT, SadikC, KlotzLO, YoshimotoT, KuhnH, SiesH.Polyphenols of cocoa: inhibition of mammalian 15-lipoxygenase. Biol Chem382:1687–1696, 2001.
7.
PearsonDA, SchmitzHH, LazarusSA, KeenCL. Inhibition of in vitro low-density lipoprotein oxidation by oligomeric procyanidins present in chocolate and cocoas. Methods Enzymol335:350–360, 2001.
8.
HeissC, DejamA, KleinbongardP, ScheweT, SiesH, KelmM.Vascular effects of cocoa rich in flavan-3-ols. JAMA290:1030–1031, 2003.
9.
TaubertD, BerkelsR, RoesenR, KlausW.Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA290:1029–1030, 2003.
10.
MackenzieGG, CarrasquedoF, DelfinoJM, KeenCL, FragaCG, OteizaPI. Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells. FASEB J, 12 Nov, 2003 (E-publication).
11.
KondoK, HiranoR, MatsumotoA, IgarashiO, ItakuraH.Inhibition of LDL oxidation by cocoa. Lancet348:1514, 1996.
12.
Kris-EthertonPM, KeenCL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol13:41–49, 2002.
13.
PearsonDA, PaglieroniTG, ReinD, WunT, SchrammDD, WangJF, HoltRR, GosselinR, SchmitzHH, KeenCL. The effects of flavonol-rich cocoa and aspirin on ex vivo platelet function. Thromb Res106:191–197, 2002.
14.
FoltsJD. Potential health benefits from the flavonoids in grape products on vascular disease. Adv Exp Med Biol505:95–111, 2002.
15.
ReinD, PaglieroniTG, WunT, PearsonDA, SchmitzHH, GosselinR, KeenCL. Cocoa inhibits platelet activation and function. Am J Clin Nutr72:30–35, 2000.
16.
MurphyKJ, ChronopoulosAK, SinghI, FrancisMA, MoriartyH, PikeMJ, TurnerAH, MannNJ, SinclairAJ. Dietary flavonols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr77:1466–1473, 2003.
SchroederP, KlotzLO, SiesH.Amphiphilic properties of (–)-epicatechin and their significance for protection of cells against peroxynitrite. Biochem Biophys Res Commun307:69–73, 2003.
19.
VerstraetenSV, KeenCL, SchmitzHH, FragaCG, OteizaPI. Flavan-3-ols and procyanidins protect liposomes against lipid oxidation and disruption of the bilayer structure. Free Radic Biol Med34:84–92, 2003.
20.
LotitoSB, Actis-GorettaL, RenartML, CaligiuriM, ReinD, SchmitzHH, SteinbergFM, KeenCL, FragaCG. Influence of oligomer chain length on the antioxidant activity of procyanidins. Biochem Biophys Res Commun276:945–951, 2000.
21.
OttavianiJI, CarrasquedoF, KeenCL, LazarusSA, SchmitzHH, FragaCG. Influence of flavan-3-ols and procyanidins on UVC-mediated formation of 8-oxo-7,8-dihydro-2′-deoxyguanosine in isolated DNA. Arch Biochem Biophys406:203–208, 2002.
22.
MaoTK, PowellJJ, Van de WaterJ, KeenCL, SchmitzHH, HammerstoneJF, GershwinME. The effect of cocoa procyanidins on the transcription and secretion of interleukin 1β in peripheral blood mononuclear cells. Life Sci66:1377–1386, 2000.
23.
MaoTK, Van De WaterJ, KeenCL, SchmitzHH, GershwinME. Cocoa flavonols and procyanidins promote transforming growth factor-beta1 homeostasis in peripheral blood mononuclear cells. Exp Biol Med (Maywood)228:93–99, 2003.
24.
SanbongiC, SuzukiN, SakaneT.Polyphenols in chocolate, which have antioxidant activity, modulate immune function in humans in vitro. Cell Immunol177:129–136, 1997.
25.
HertogMGL, FeskensEJM, HollmanPCH, KatanMB, KromhoutD.Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet342:1007–1011, 1993.
26.
KeliSO, HertogMG, FeskensEJ, KromhoutD.Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med156:637–642, 1996.
27.
SteinmetzKA, PotterJD. Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control2:325–357, 1991.
28.
SteinbergFM, BeardenMM, KeenCL. Cocoa and chocolate flavonoids: implications for cardiovascular health. J Am Diet Assoc103:215–223, 2003.
29.
ArtsIC, JacobsDRJr., GrossM, HarnackLJ, FolsomAR. Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States). Cancer Causes Control13:373–382, 2002.
30.
RobinsonD, HeF, PretlowT, KungHJ. A tyrosine kinase profile of prostate carcinoma. Proc Natl Acad Sci U S A93:5958–5962, 1996.
31.
KungHJ, ChenHC, RobinsonD.Molecular profiling of tyrosine kinases in normal and cancer cells. J Biomed Sci5:74–78, 1998.
32.
FerraraN, ClappC, WeinerR.The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology129:896–900, 1991.
33.
CarnesecchiS, SchneiderY, LazarusSA, CoehloD, GosseF, RaulF.Flavonols and procyanidins of cocoa and chocolate inhibit growth and polyamine biosynthesis of human colonic cancer cells. Cancer Lett175:147–155, 2002.
34.
YamagishiM, NatsumeM, OsakabeN, OkazakiK, FurukawaF, ImazawaT, NishikawaA, HiroseM.Chemoprevention of lung carcinogenesis by cacao liquor proanthocyanidins in a male rat multi-organ carcinogenesis model. Cancer Lett191:49–57, 2003.
35.
PianettiS, GuoS, KavanaghKT, SonensheinGE. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res62:652–655, 2002.
36.
LamyPJ, PujolP, ThezenasS, KramarA, RouanetP, GuilleuxF, GrenierJ.Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapy. Breast Cancer Res Treat76:65–71, 2002.
37.
ArtsIC, HollmanPC, KromhoutD.Chocolate as a source of tea flavonoids. Lancet354:488, 1999.
38.
BorchersA, KeenC, HannumS, GershwinM.Cocoa and chocolate: composition, bioavailability, and health implications. J Medicinal Food3:77–105, 2000.
39.
KlotzLO, SiesH.Defenses against peroxynitrite: selenocompounds and flavonoids. Toxicol Lett 140–141:125–132, 2003.
40.
BenharM, EngelbergD, LevitzkiA.ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep3:420–425, 2002.
ManniA.Polyamine involvement in breast cancer phenotype. In Vivo16:493–500, 2002.
43.
HudsonLG, ThompsonKL, XuJ, GillGN. Identification and characterization of a regulated promoter element in the epidermal growth factor receptor gene. Proc Natl Acad Sci U S A87:7536–7540, 1990.
44.
YenL, YouXL, Al MoustafaAE, BatistG, HynesNE, MaderS, MelocheS, Alaoui-JamaliMA. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis. Oncogene19:3460–3469, 2000.
45.
BabaS, OsakabeN, NatsumeM, TeraoJ.Absorption and urinary excretion of procyanidin B2 [epicatechin-(4beta-8)-epicatechin] in rats. Free Radic Biol Med33:142–148, 2002.
46.
NatsumeM, OsakabeN, OyamaM, SasakiM, BabaS, NakamuraY, OsawaT, TeraoJ.Structures of (–)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (–)-epicatechin: differences between human and rat. Free Radic Biol Med34:840–849, 2003.
47.
ZhuQY, HoltRR, LazarusSA, OrozcoTJ, KeenCL. Inhibitory effects of cocoa flavonols and procyanidin oligomers on free radical-induced erythrocyte hemolysis. Exp Biol Med (Maywood)227:321–329, 2002.
48.
RiosLY, BennettRN, LazarusSA, RemesyC, ScalbertA, WilliamsonG.Cocoa procyanidins are stable during gastric transit in humans. Am J Clin Nutr76:1106–1110, 2002.
